Heron Therapeutics (HRTX) Shares Issued (2016 - 2025)
Historic Shares Issued for Heron Therapeutics (HRTX) over the last 14 years, with Q3 2025 value amounting to $19.3 million.
- Heron Therapeutics' Shares Issued changed N/A to $19.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.7 million, marking a year-over-year decrease of 3210.14%. This contributed to the annual value of $637000.0 for FY2024, which is 9785.92% down from last year.
- Per Heron Therapeutics' latest filing, its Shares Issued stood at $19.3 million for Q3 2025.
- In the past 5 years, Heron Therapeutics' Shares Issued ranged from a high of $74.4 million in Q3 2022 and a low of -$18000.0 during Q4 2022
- Its 5-year average for Shares Issued is $15.7 million, with a median of $764500.0 in 2021.
- In the last 5 years, Heron Therapeutics' Shares Issued soared by 7519.84% in 2021 and then plummeted by 10295.08% in 2022.
- Quarter analysis of 5 years shows Heron Therapeutics' Shares Issued stood at $610000.0 in 2021, then plummeted by 102.95% to -$18000.0 in 2022, then surged by 161494.44% to $29.1 million in 2023, then plummeted by 98.41% to $462000.0 in 2024, then skyrocketed by 4066.88% to $19.3 million in 2025.
- Its last three reported values are $19.3 million in Q3 2025, $462000.0 for Q4 2024, and $29.1 million during Q3 2023.